Investors and Media

Scientific presentations

Scientific presentations and posters

Below are several selected presentations and posters which can be downloaded as PDFs.

Cystic Fibrosis (CF)

Annual North American Cystic Fibrosis Conference - Denver, CO, USA
October 18-20, 2018. Scientific poster: Results From Two Completed Phase I Studies With POL6014-A Novel Inhaled Neutrophil Elastase Inhibitor


Duchenne Muscular Dystrophy (DMD)

23rd International Congress of the World Muscle Society (WMS) – Mendoza, Argentina
October 2-6, 2018. Scientific poster presentations.

15th International Congress on Neuromuscular Diseases - ICNMD (Vienna, Austria)
July 6-10, 2018. Scientific poster presentations.

2018 Parent Project Muscular Dystrophy Annual Conference (Scottsdale, Arizona, USA)
June 28-30, 2018. Presentation by Kristina Sjöblom Nygren, CMO

16th International Conference on Duchenne and Becker Muscular Dystrophy (Rome)
February 16-18, 2018. Presentation by Thomas Meier, CEO

American Thoracic Society 113th Annual Conference (Washington, DC)
May 22, 2017. Poster presentation: Correlation between volume- and flow-related pulmonary function outcomes in patients with DMD
May 23, 2017. Poster presentation: Effect of Idebenone on Bronchopulmonary Adverse Events and Hospitalizations in Patients with Duchenne Muscular Dystrophy (DMD)


Leber Hereditary Optic Neuropathy (LHON)

ARVO - Annual Meeting of The Association for Research in Vision and Ophthalmology (Seattle)
May 4, 2016. Poster presentation by Shabir Hasham: Treatment of visual impairment in patients with Leber’s hereditary optic neuropathy using idebenone (Raxone®)

EUNOS - 12th Meeting of European Neuro-Ophthalmological Society (Ljubljana)
June 24, 2015. Presentation by Günther Metz: Clinical experience with idebenone (Raxone®) in the treatment of patients with Leber’s hereditary optic neuropathy

EVER - Annual Meeting of The European Association for Vision and Eye Research (Nice)
October 8, 2015. Poster presentation by Claudia Catarino: Clinical experience with idebenone (Raxone®) in the treatment of patients with Leber’s hereditary optic neuropathy (LHON)